Skip to content

Fire needle acupuncture on acupoints 'Intestinal Disease Prescription' for the treatment of liver stagnation and spleen deficiency type diarrhea-predominant irritable bowel syndrome: a randomized controlled trial

Fire needle acupuncture on acupoints 'Intestinal Disease Prescription' for the treatment of liver stagnation and spleen deficiency type diarrhea-predominant irritable bowel syndrome: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000541
Enrollment
Unknown
Registered
2026-03-13
Start date
2024-12-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome with Diarrhoea

Interventions

Treatment group:Fire needle combined with filiform needle, alternately needling the acupuncture points around the 'Intestinal Disease Prescription' on the left and right sides
Control group:Oral tiotropium bromide tablets for 4 weeks

Sponsors

Shanxi Province Acupuncture Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meets the above Western medicine diagnostic criteria; (2) Aged 18-65 years, of any gender; (3) IBS-SSS score =75 points; (4) No organic intestinal lesions; (5) Has not taken any anti-diarrheal drugs, analgesics, antibiotics, and/or probiotics or other drugs related to IBS-D treatment within one month before entering this study; (6) Not participating in any other clinical study at the same time; (7) Patient voluntarily cooperates with this study and signs the informed consent form. Those meeting all the above 7 criteria can be included in the study.

Exclusion criteria

Exclusion criteria: (1) Other digestive system diseases presenting with diarrhea; (2) Patients with severe primary diseases or systemic diseases affecting gastrointestinal motility; (3) Individuals who are unconscious, unable to express subjective feelings, or unable to cooperate with treatment; (4) Those with allergies, pregnant women, and breastfeeding women; (5) Individuals who cannot tolerate acupuncture, or have infection or ulcers at the treatment site; (6) Those unwilling to sign the informed consent form. Meeting any of the above criteria will result in exclusion from the study.

Design outcomes

Primary

MeasureTime frame
Irritable Bowel Syndrome Symptom Severity Scale;IBS Weekly Bowel Habit Bristol Score;

Secondary

MeasureTime frame
IBS defecation state questionnaire;Hamilton Anxiety Rating Scale;

Countries

China

Contacts

Public ContactCao yuxia

Shanxi Province Acupuncture Hospital

cyxzijun@163.com13593176059

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026